| Case Page

 | Case Page |

Case Page

 

Teva Pharmaceutical Industries Limited : American Depositary Shares

Case Summary

Teva Pharmaceutical Industries Limited : American Depositary Shares Securities Litigation

Case Summary

Case Status:    ONGOING    
On or around 06/22/2018 (Ongoing date of last review)

Filing Date: November 06, 2016

According to the law firm press release, the lawsuit alleges throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Teva was engaging and/or had engaged in conduct that would result in an antitrust investigation by the U.S. Department of Justice (“DOJ”) and the State of Connecticut Office of the Attorney General; (2) the DOJ investigation and the underlying conduct could cause U.S. prosecutors to file criminal charges against Teva by the end of 2016 for suspected price collusion; (3) in turn, Teva lacked effective internal controls over financial reporting; and (4) as a result, Teva’s public statements were materially false and misleading at all relevant times.

On April 3, 2017, the Court issued an Order consolidating cases and transferring the consolidated action to the District of Connecticut.

On July 11, 2017, the Court appointed Lead Plaintiff and Counsel. Lead Plaintiff filed a Complaint on August 2.

An amended Complaint was filed on September 5, 2017. This was followed by the filing of the consolidated Complaint on September 11. Defendants filed Motions to Dismiss the consolidated Complaint on December 1. On April 3, 2018, the Court issued an Order granting Defendants' Motions to Dismiss the consolidated Complaint. Lead Plaintiff was given leave to file an amended consolidated Complaint. Lead Plaintiff filed an amended consolidated Complaint on June 22.

Company & Securities Information

Defendant: Teva Pharmaceutical Industries Limited

COMPANY INFORMATION:

Sector: Healthcare
Industry: Major Drugs
Headquarters: Israel

SECURITIES INFORMATION:

Ticker Symbol: TEVA
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.

First Identified Complaint

Amram Galmi, et al. v. Teva Pharmaceutical Industries Limited , et al.

COURT: D. Connecticut
DOCKET #: 16-CV-08259
JUDGE: Hon. Terry J. Hatter, Jr
DATE FILED: 11/06/2016
CLASS PERIOD START: 02/10/2015
CLASS PERIOD END: 11/03/2016
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. The Rosen Law Firm, P.A. (New Los Angeles)
    355 South Grand Ave, Suite 2450, The Rosen Law Firm, P.A. (New Los Angeles), CA 90071
    (213) 785-2610 (213) 226-4684 ·
First Identified Complaint (FIC) Filings:
No Document Title Filing Date
1 Class Action Complaint for Violation of the Federal Securities Laws 11/06/2016
2 Order 04/03/2017

Reference Complaint

Ontario Teachers' Pension Plan Board, et al. v. Teva Pharmaceutical Industries Limited , et al.

COURT: D. Connecticut
DOCKET #: 17-CV-00558
JUDGE: Hon. Terry J. Hatter, Jr
DATE FILED: 06/22/2018
CLASS PERIOD START: 02/06/2014
CLASS PERIOD END: 08/03/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Bleichmar Fonti & Auld LLP
    7 Times Square, 27th Floor, Bleichmar Fonti & Auld LLP, NY 10036
    212.789.1340 ·
  2. Carmody Torrance Sandak & Hennessey, LLP
    707 Summer Street 3rd Floor , Carmody Torrance Sandak & Hennessey, LLP, CT 06901
    203.425.4200 203-325-8608 ·
Reference Complaint (REF) Filings:
No Document Title Filing Date
1 Ruling on Motions for Appointment as Lead Plaintiff 07/11/2017
2 Class Action Complaint for Violation of the Securities Act of 1933 08/02/2017
3 Amended Class Action Complaint for Violation of the Securities Act of 1933 09/05/2017
4 Consolidated Class Action Complaint 09/11/2017
5 Courtroom Minutes - Civil 04/03/2018
6 U.S. District Court Civil Docket 06/22/2018
7 Amended Consolidated Class Action Complaint 06/22/2018
 
 

Cases